TITLE

Indications for Systemic Antibiotic Prophylaxis in Neutropenic Patients

AUTHOR(S)
Spiers, A. S. D.; Tattersall, M. H. N.; Gaya, H.
PUB. DATE
November 1974
SOURCE
British Medical Journal;11/23/1974, Vol. 4 Issue 5942, p440
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64322234

 

Related Articles

  • Evidence-based medicine.  // Cortlandt Forum;8/25/2005, Vol. 18 Issue 8, p48 

    Discusses the use of antibiotic prophylaxis for the neutropenic chemotherapy patient. Guidelines on the use of prophylaxis for neutropenic patients, according to the Infectious Diseases Society of America; Reference to a new study which challenges the society's recommendation; Reduction in...

  • What to do when use of vancomycin is not recommended: Alternative therapeutic approaches for...  // Formulary;Sep98, Vol. 33 Issue 9, p886 

    Offers alternative therapeutic approaches for selected clinical situations when vancomycin use is not recommended. Includes surgical prophylaxis or digestive tract decontamination; Empiric therapy of febrile neutropenic patients; Systemic/local prophylaxis of infection in indwelling peripheral...

  • Prevention of Bacterial Infection in Neutropenic Patients with Hematologic Malignancies.  // Annals of Internal Medicine;7/1/91, Vol. 115 Issue 1, p7 

    Compares the efficacy of norfloxacin and ciproflaxacin in preventing bacterial infection in neutropenic patients. Major cause of morbidity and mortality in patients with cancer and prolonged neutropenia; Use of parenteral antibiotics; Important consideration for clinicians in evaluating...

  • Antibiotic Prophylaxis Reduces Mortality Rate in Neutropenic Patients. K. B. // Access;Dec2005, Vol. 19 Issue 10, p48 

    The article reports on antibiotic prophylaxis, which reduces mortality rate in neutropenic patients. A meta-analysis of 95 randomized controlled trials conducted from 1973 to 2004 was performed. The aim of the meta-analysis was to determine whether mortality and infection reduced after...

  • Stopping Antibiotic Therapy in Neutropenic Patients. DiNubile, Mark J. // Annals of Internal Medicine;Feb88, Vol. 108 Issue 2, p289 

    Offers guidelines for withdrawing antibiotic therapy in persistently neutropenic patients. Pressure to continue antibiotic therapy in neutropenic patients; Factors that might influence the length of antibiotic treatment in neutropenic patients; Recommended approach to neutropenic patients who...

  • New CDA Position Statement on Dental Patients with Orthopedic Implants.  // Journal of the Canadian Dental Association;2013, Vol. 79 Issue 3, p1 

    The article focuses on the revised guidelines of Canadian Dental Association on prophylaxis and informs that routine antibiotic prophylaxis is not indicated for dental patients with total joint replacement.

  • A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients. Nucci, Marcio; Biasoli, Irene; Akiti, Tiyomi; Silveira, Fernanda; Solza, Cristina; Barreiros, Gloria; Spector, Nelson; Derossi, Andrea; Pucheri, Wolmar // Clinical Infectious Diseases;2/1/2000, Vol. 30 Issue 2, p300 

    Evaluates efficacy of itraconazole capsules in prophylaxis for fungal infections in neutropenic cancer patients. Mortality associated with systemic fungal infections; Fungal infections and need for amphotericin B; Itraconazole serum levels.

  • Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients. Gafter-Gvili, Anat; Fraser, Abigail; Paul, Mical; Leibovici, Leonard // Annals of Internal Medicine;6/21/2005, Vol. 142 Issue 12, p979 

    Background: Bacterial infections are a major cause of illness and death in patients who are neutropenic after chemotherapy treatment for cancer. Trials have shown the efficacy of antibiotic prophylaxis in decreasing the incidence of bacterial infections but not in reducing mortality rates....

  • Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors. Neumann, S.; Krause, S.; Maschmeyer, G.; Schiel, X.; Lilienfeld-Toal, M. // Annals of Hematology;Apr2013, Vol. 92 Issue 4, p433 

    Bacterial infections are the most common cause for treatment-related mortality in patients with neutropenia after chemotherapy. Here, we discuss the use of antibacterial prophylaxis against bacteria and Pneumocystis pneumonia (PCP) in neutropenic cancer patients and offer guidance towards the...

  • Efficacy of Clarithromycin in Preventing Viridans Streptococcal Bacteremia following Autologous Stem Cell Transplantation. Naqvi, B.; Dorsky, D.; Ali, S. A.; Feingold, J. M.; Edwards, R. L.; Bona, R. D.; Clive, J.; Tutschka, P. J.; Bilgrami, S. // Infection;Aug2001, Vol. 29 Issue 4, p201 

    Background: In a study involving 200 patients, we previously found that 17.5% of patients developed viridans streptococcal (VS) bacteremia following autologous peripheral blood stem cell transplantation (aPBSCT) when ciprofloxacin or ciprofloxacin plus ampicillin was used for prophylaxis....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics